Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    GRI Bio Inc.

    NASDAQ: GRI · Real-Time Price · USD
    1.33
    -0.01 (-0.75%)
    At close: Jun 17, 2025, 1:51 PM

    GRI Bio Statistics

    Share Statistics

    GRI Bio has 2.35M shares outstanding. The number of shares has increased by -1.53% in one year.

    Shares Outstanding

    n/a
    		 2.35M

    Shares Change (YoY)

    n/a
    		 -1.53%

    Shares Change (QoQ)

    n/a
    		 -0.32%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 2.35M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,303

    FTD / Avg. Volume

    n/a
    		 0.26%

    Short Selling Information

    The latest short interest is 129.57K, so 5.52% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 129.57K

    Short % of Shares Out

    n/a
    		 5.52%

    Short % of Float

    n/a
    		 5.57%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.31 and the forward PE ratio is -0.64. GRI Bio's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.31

    Forward PE

    n/a
    		 -0.64

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.64

    P/FCF Ratio

    n/a
    		 -0.3

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for GRI Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 3.43

    Quick Ratio

    n/a
    		 3.43

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,735,666.67

    Employee Count

    n/a
    		 3

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -97.25% in the last 52 weeks. The beta is -2.1, so GRI Bio's price volatility has been lower than the market average.

    Beta

    n/a
    		 -2.1

    52-Week Price Change

    n/a
    		 -97.25%

    50-Day Moving Average

    n/a
    		 1.5

    200-Day Moving Average

    n/a
    		 7.96

    Relative Strength Index (RSI)

    n/a
    		 41.71

    Average Volume (20 Days)

    n/a
    		 508,930

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -8.23M

    Net Income

    n/a
    		 -8.21M

    EBITDA

    n/a
    		 -8.23M

    EBIT

    n/a
    		 -8.23M

    Earnings Per Share (EPS)

    n/a
    		 -55.21
    Full Income Statement

    Balance Sheet

    The company has 5.03M in cash and 119K in debt, giving a net cash position of 4.91M.

    Cash & Cash Equivalents

    n/a
    		 5.03M

    Total Debt

    n/a
    		 119K

    Net Cash

    n/a
    		 4.91M

    Retained Earnings

    n/a
    		 -39.74M

    Total Assets

    n/a
    		 5.74M

    Working Capital

    n/a
    		 3.98M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -8.61M and capital expenditures 0, giving a free cash flow of -8.61M.

    Operating Cash Flow

    n/a
    		 -8.61M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -8.61M

    FCF Per Share

    n/a
    		 -46.98
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    GRI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for GRI is $22, which is 1541.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $22

    Price Target Difference

    n/a
    		 1541.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 24, 2025. It was a backward split with a ratio of 1:17.

    Last Split Date

    n/a
    		 Feb 24, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:17

    Scores

    Altman Z-Score

    n/a
    		 -12.48

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist